Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
197.50    -2.50 (-1.25%)
Bid:
190.00
Ask:
205.00
Spread: 15.00 (7.895%)
Market Cap: £33.59m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

1 Oct 2021 14:15

RNS Number : 7847N
Synectics PLC
01 October 2021
 

 

 

RNS

 

1 October 2021

 

 

 

Synectics plc

("Synectics" or the "Company")

 

Director/PDMR dealings

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, has been notified that earlier today, the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") purchased a total of 14,843 ordinary shares of 20 pence each in the Company at a price of £1.05 per share in accordance with the ESAP's rules and on behalf of all ESAP participants, in respect of the six-month accumulation period ended on 30 September 2021.

 

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares at the end of the six-month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance, the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period which was £1.35.

 

As a result of this purchase, the Company has been notified that the following Executive Directors and PDMRs have acquired the following interests in shares of the Company:

 

Name

Position

Status

Number of Shares purchased by the Trustee

Paul Webb

Chief Executive

Executive Director

857

David Bedford

Finance Director

Executive Director

857

Greg Alcorn

Divisional Director

PDMR

857

David Lowe

Divisional Director

PDMR

857

 

In addition, David Bedford, Finance Director of the Company has notified the Company that he too purchased 5,000 ordinary shares of 20p each in the Company at £1.05 per share earlier today.

 

Following these purchases, the interests of Messrs Webb, Bedford, Alcorn and Lowe in the shares of the Company are as follows:

 

Name

Shares Held

Interest in Shares in Share Schemes

Resultant Total Interest

% of Issued Share Capital

Paul Webb

57,115

536,327

593,442

3.33%

David Bedford

20,000

186,857

206,857

1.16%

Greg Alcorn

-

25,655

25,655

0.14%

David Lowe

15,000

43,177

58,177

0.33%

 

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Claire Stewart, Company Secretary

email: legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / David Coaten / Henry Willcocks

 

 

 Ends

 

About Synectics plc

 

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

 

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

 

Find out more at www.synecticsplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADEFEFLFFFA
Date   Source Headline
10th Feb 20217:00 amRNSLetter of Intent and Notification of Results Date
7th Jan 20217:00 amRNSSynectics’ S-Bahn project goes live
15th Dec 20207:00 amRNSTrading Update
1st Dec 20207:00 amRNSSynectics appoints Dr Kerstin Wendt
26th Nov 20207:00 amRNSDirector/PDMR Shareholding
19th Nov 20207:36 amRNSDirector/PDMR Shareholding
18th Nov 202011:53 amRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSContract Win
2nd Oct 202011:02 amRNSDirector/PDMR dealings
29th Sep 20207:00 amRNSTrading Update
12th Aug 20207:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirectors' / PDMRs' Interests in Shares
30th Jul 20202:03 pmRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSContract Wins for 'next generation' Irish Buses
27th Jul 20204:40 pmRNSSecond Price Monitoring Extn
27th Jul 20204:35 pmRNSPrice Monitoring Extension
27th Jul 20207:00 amRNSHolding(s) in Company
23rd Jul 20208:22 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSInterim Results
25th Jun 20209:12 amRNSHolding(s) in Company
16th Jun 20207:00 amRNSMajor Contract Win and Notice of Interim Results
22nd May 20207:00 amRNSContract Wins with Long Term Customers
23rd Apr 202011:49 amRNSResult of AGM
23rd Apr 20207:00 amRNSBusiness Update
6th Apr 202012:24 pmRNSRevised Arrangements for Annual General Meeting
2nd Apr 20209:11 amRNSDirector/PDMR Shareholding
23rd Mar 20202:28 pmRNSBusiness Update: COVID-19
23rd Mar 20201:48 pmRNSAvailability of Report and Accounts and AGM
11th Mar 20204:23 pmRNSDirector/PDMR Shareholding
11th Mar 202012:11 pmRNSHolding(s) in Company
6th Mar 20201:59 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSSettlement of Legal Claim
25th Feb 20207:00 amRNSFinal Results
11th Feb 20204:12 pmRNSHolding(s) in Company
7th Feb 20202:33 pmRNSHolding(s) in Company
7th Feb 202010:43 amRNSReplacement - Holding(s) in Company
7th Feb 20207:00 amRNSNotification of Final Results
6th Feb 20204:58 pmRNSHolding(s) in Company
30th Jan 202012:17 pmRNSReplacement - Holding(s) in Company
28th Jan 20208:58 amRNSHolding(s) in Company
23rd Jan 20209:55 amRNSDirectorate Changes
13th Dec 201912:00 pmRNSDirectorate Change
21st Nov 20198:42 amRNSChange of Registered Office
5th Nov 20198:51 amRNSHolding(s) in Company
30th Oct 201911:06 amRNSSecond Price Monitoring Extn
30th Oct 201911:00 amRNSPrice Monitoring Extension
30th Oct 20197:00 amRNSTrading Update
2nd Oct 20194:12 pmRNSDirector/PDMR Shareholding
23rd Jul 20198:31 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.